The Cooper Companies, Inc.
COO
Kedudukan dalam Saham
#1899
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Harga Saham
$59.06
Modal Pasaran
$11.23B
Perubahan (1 hari)
1.54%
Perubahan (1 tahun)
-21.25%
Negara
US
Perdagangan The Cooper Companies, Inc. (COO)
Kategori
Healthcare
Nisbah P/E bagi The Cooper Companies, Inc. (COO)
Nisbah P/E pada October 2026 TTM: 18.73
Menurut laporan kewangan dan harga saham terkini The Cooper Companies, Inc., nisbah P/E semasa (TTM) ialah 18.73. Pada akhir 2024, syarikat mempunyai nisbah P/E sebanyak 53.07.
Sejarah nisbah P/E bagi The Cooper Companies, Inc. dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | 18.73 | -49.78% |
| 2025 | 37.30 | -29.73% |
| 2024 | 53.07 | 1.18% |
| 2023 | 52.45 | 50.14% |
| 2022 | 34.94 | 1,878.19% |
| 2021 | 1.77 | -89.25% |
| 2020 | 16.43 | 113.76% |
| 2019 | 7.69 | -66.09% |
| 2018 | 22.67 | 187.78% |
| 2017 | 7.88 | 1.07% |
| 2016 | 7.79 | -14.15% |
| 2015 | 9.08 | 24.40% |
| 2014 | 7.30 | 37.62% |
| 2013 | 5.30 | 14.51% |
| 2012 | 4.63 | -0.07% |
| 2011 | 4.63 | -7.35% |
| 2010 | 5.00 | 59.02% |
| 2009 | 3.14 | 11.08% |
| 2008 | 2.83 | -106.75% |
| 2007 | -41.94 | -533.01% |
| 2006 | 9.69 | 25.13% |
| 2005 | 7.74 | 27.19% |
| 2004 | 6.09 | 23.42% |
| 2003 | 4.93 | 18.96% |
| 2002 | 4.15 | -13.54% |
| 2001 | 4.79 | 9.50% |
| 2000 | 4.38 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 47.48 | 153.52% |
US
|
|
| 27.43 | 46.42% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | 203.76% |
US
|
|
| - | - |
CH
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.